Ding Xiaoyan, Yang Jingwei, Li Lan, Yang Na, Lan Ling, Huang Guoning, Ye Hong
Chongqing Key Laboratory of Human Embryo Engineering, Chongqing Clinical Research Center for Reproductive Medicine, Reproductive and Genetics Institute, Chongqing Health Center for Women and Children, 400013, Chongqing, China.
BMC Pregnancy Childbirth. 2021 Mar 12;21(1):207. doi: 10.1186/s12884-021-03698-5.
Along with progress in embryo cryopreservation, especially the vitrification, freeze all strategy has become more acceptable than ever. Some studies have found comparable or higher live birth rate with frozen embryo transfer (FET) than with fresh embryo transfer(ET)in gonadotropin releasing hormone antagonist (GnRH-ant) protocol. However from our literature research, there have been no reports about live birth rate comparison between fresh ET and FET with gonadotropin releasing hormone agonist (GnRH-a) long protocol. The aim of this study is to retrospectively investigate whether patients benefit from freeze all strategy in GnRH-a protocol using real-world data.
This is a retrospective cohort study, in which women undergoing fresh ET or FET with GnRH-a long protocol at Chongqing Reproductive and Genetics Institute from January 2016 to December 2018 were evaluated. The primary outcome was live birth rate. The secondary outcomes were implantation rate, clinical pregnancy rate, pregnancy loss and ectopic pregnancy rate.
A total of 7,814 patients met inclusion criteria, implementing 5,216 fresh ET cycles and 2,598 FET cycles, respectively. The demographic characteristics of the patients were significantly different between fresh ET and FET groups, except BMI. After controlling for a broad range of potential confounders including age, infertility duration, BMI, AMH, number of oocytes retrieved and of available embryos, multivariate logistic regression analysis demonstrated that there was no significant difference in clinical pregnancy rate, ectopic pregnancy rate and pregnancy loss rate between two groups (all P > 0.05). However, the implantation rate and live birth rate in fresh ET group were significantly higher than FET group (P < 0.001 and P = 0.012, respectively).
Under GnRH-a long protocol, compared to FET, fresh ET was associated with higher implantation rate and live birth rate in infertile patients that underwent in vitro fertilization (IVF). The freeze all strategy should be individualized and made with caution especially with GnRH-a long protocol.
随着胚胎冷冻技术的进步,尤其是玻璃化冷冻技术的发展,“全冷冻”策略比以往任何时候都更易被接受。一些研究发现,在促性腺激素释放激素拮抗剂(GnRH-ant)方案中,冷冻胚胎移植(FET)的活产率与新鲜胚胎移植(ET)相当或更高。然而,根据我们的文献研究,尚无关于促性腺激素释放激素激动剂(GnRH-a)长方案下新鲜ET与FET活产率比较的报道。本研究的目的是利用真实世界数据,回顾性调查在GnRH-a方案中患者是否能从“全冷冻”策略中获益。
这是一项回顾性队列研究,对2016年1月至2018年12月在重庆生殖与遗传研究所接受GnRH-a长方案新鲜ET或FET的女性进行评估。主要结局是活产率。次要结局是着床率、临床妊娠率、妊娠丢失率和异位妊娠率。
共有7814例患者符合纳入标准,分别实施了5216个新鲜ET周期和2598个FET周期。除体重指数(BMI)外,新鲜ET组和FET组患者的人口统计学特征存在显著差异。在控制了包括年龄、不孕年限、BMI、抗缪勒管激素(AMH)、获卵数和可用胚胎数等广泛的潜在混杂因素后,多因素logistic回归分析表明,两组的临床妊娠率、异位妊娠率和妊娠丢失率无显著差异(均P>0.05)。然而,新鲜ET组的着床率和活产率显著高于FET组(分别为P<0.001和P=0.012)。
在GnRH-a长方案下,与FET相比,新鲜ET在接受体外受精(IVF)的不孕患者中具有更高的着床率和活产率。“全冷冻”策略应个体化制定,尤其是在GnRH-a长方案中要谨慎使用。